Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Next generation sequencing-based salivary biomarkers in oral squamous cell carcinoma

´ëÇѱ¸°­¾Ç¾È¸é¿Ü°úÇÐȸÁö 2022³â 48±Ç 1È£ p.3 ~ 12
Sodnom-Ish Buyanbileg, ¾î¹Ì¿µ, ¸íÈÆ, ÀÌÁ¾È£, ±è¼º¹Î,
¼Ò¼Ó »ó¼¼Á¤º¸
 ( Sodnom-Ish Buyanbileg ) - Seoul National University School of Dentistry Department of Oral and Maxillofacial Surgery
¾î¹Ì¿µ ( Eo Mi-Young ) - Seoul National University School of Dentistry Department of Oral and Maxillofacial Surgery
¸íÈÆ ( Myoung Hoon ) - Seoul National University School of Dentistry Department of Oral and Maxillofacial Surgery
ÀÌÁ¾È£ ( Lee Jong-Ho ) - Seoul National University School of Dentistry Department of Oral and Maxillofacial Surgery
±è¼º¹Î ( Kim Soung-Min ) - Seoul National University School of Dentistry Department of Oral and Maxillofacial Surgery

Abstract


Selection of potential disease-specific biomarkers from saliva or epithelial tissues through next generation sequencing (NGS)-based protein studies has recently become possible. The early diagnosis of oral squamous cell carcinoma (OSCC) has been difficult, if not impossible, until now due to the lack of an effective OSCC biomarker and efficient molecular validation method. The aim of this study was to summarize the advances in the application of NGS in cancer research and to propose potential proteomic and genomic saliva biomarkers for NGS-based study in OSCC screening and diagnosis programs. We have reviewed four categories including definitions and use of NGS, salivary biomarkers and OSCC, current biomarkers using the NGS-based technique, and potential salivary biomarker candidates in OSCC using NGS.

Å°¿öµå

Next generation sequencing; Saliva; Biomarkers; Early diagnosis; Oral squamous cell carcinoma

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed